HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Triamcinolone acetonide bevacizumab performance in treatment and idiopathic macular spider veins].

Abstract
This article evaluated the efficacy of intravitrean injection of anti VEGF agents and triamcinolon in the treatment of macular telangiectasis. The patients were followed six months. We practiced fluorescein angiography, optical coherence tomography. We measured the thickening of macular edema and best corrected of visual acuity.
AuthorsBeatrice Cerbulescu, Ana-Lavinia Taina, Monica Dinita, Raluca Malaeanu, Robertina Radocea, B Carstocea
JournalOftalmologia (Bucharest, Romania : 1990) (Oftalmologia) Vol. 54 Issue 1 Pg. 101-9 ( 2010) ISSN: 1220-0875 [Print] Romania
Vernacular TitleEficacitatea bevacizumabului si triamcinolonului acetonid in tratamentul telangiectaziilor idiopatice maculare.
PMID20540378 (Publication Type: Case Reports, English Abstract, Journal Article)
Chemical References
  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Glucocorticoids
  • Bevacizumab
  • Triamcinolone Acetonide
Topics
  • Adult
  • Angiogenesis Inhibitors (administration & dosage, therapeutic use)
  • Antibodies, Monoclonal (administration & dosage, therapeutic use)
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab
  • Drug Therapy, Combination
  • Glucocorticoids (administration & dosage, therapeutic use)
  • Humans
  • Injections, Intraocular
  • Macular Edema (diagnosis, drug therapy)
  • Male
  • Middle Aged
  • Telangiectasis (diagnosis, drug therapy)
  • Tomography, Optical Coherence
  • Treatment Outcome
  • Triamcinolone Acetonide (administration & dosage, therapeutic use)
  • Visual Acuity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: